Currently, there are 243.07M common shares owned by the public and among those 235.64M shares have been available to trade.
The company’s stock has a 5-day price change of 36.91% and 61.59% over the past three months. IONQ shares are trading 15.01% year to date (YTD), with the 12-month market performance up to 458.60% higher. It has a 12-month low price of $6.22 and touched a high of $54.74 over the same period. IONQ has an average intraday trading volume of 21.16 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 42.16%, 69.97%, and 92.93% respectively.
Institutional ownership of IonQ Inc (NYSE: IONQ) shares accounts for 40.09% of the company’s 243.07M shares outstanding.
It has a market capitalization of $11.90B and a beta (3y monthly) value of 2.62. The earnings-per-share (ttm) stands at -$1.49. Price movements for the stock have been influenced by the stock’s volatility, which stands at 16.17% over the week and 8.05% over the month.
Analysts forecast that IonQ Inc (IONQ) will achieve an EPS of -0.14 for the current quarter, -0.15 for the next quarter and -0.73 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.17 while analysts give the company a high EPS estimate of -0.17. Comparatively, EPS for the current quarter was -0.21 a year ago. Earnings per share for the fiscal year are expected to increase by 25.64%, and -30.60% over the next financial year. EPS should grow at an annualized rate of 4.82% over the next five years, compared to -85.81% over the past 5-year period.
Looking at the support for the IONQ, a number of firms have released research notes about the stock. DA Davidson stated their Buy rating for the stock in a research note on December 19, 2024, with the firm’s price target at $50. Craig Hallum coverage for the IonQ Inc (IONQ) stock in a research note released on August 11, 2023 offered a Buy rating with a price target of $21. Morgan Stanley was of a view on April 26, 2023 that the stock is Equal-Weight, while Needham gave the stock Buy rating on June 08, 2022, issuing a price target of $9. Goldman on their part issued Neutral rating on November 22, 2021.
